The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response

Annals of Surgery

Volumn 260, Issue 2, 2014, Pages 317-328

  Li, Chang Xian ^a   Ng, Kevin Tak Pan ^a   Shao, Yan ^a   Liu, Xiao Bing ^a   Ling, Chang Chun ^a   Ma, Yuen Yuen ^a   Geng, Wei ^a   Qi, Xiang ^a   Cheng, Qiao ^a   Chung, Sookja K ^b   Lo, Chung Mau ^a   Man, Kwan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aldose reductase; Hepatic ischemia reperfusion; Inflammatory response; Macrophage; NF B

Indexed keywords

ALANINE AMINOTRANSFERASE; ALDEHYDE REDUCTASE; ASPARTATE AMINOTRANSFERASE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ZOPOLRESTAT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FATTY LIVER; GENE OVEREXPRESSION; HEPATITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER GRAFT; LIVER ISCHEMIA; LIVER REGENERATION; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL LINE; ENZYMOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LIVER; LIVER TRANSPLANTATION; MACROPHAGE; METABOLISM; NICK END LABELING; RAT; VASCULARIZATION; WESTERN BLOTTING;

ALDEHYDE REDUCTASE; ANIMALS; BLOTTING, WESTERN; CELL LINE; FATTY LIVER; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFLAMMATION; LIVER; LIVER TRANSPLANTATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84905440345     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000429     Document Type: Article

References (37)

1. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol. 2003;74:86-93.
2. Man K, Ng KT, Lo CM, et al. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways. Liver Transpl. 2007;13:1669-1677.
3. Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc. 1991;23:1538-1540.
4. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21:105-113.
5. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant. 2011;11:1563-1569.
6. Boros P, Bromberg JS. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant. 2006;6:652-658.
7. Kupiec-Weglinski JW, Busuttil RW. Ischemia and reperfusion injury in liver transplantation. Transplant Proc. 2005;37:1653-1656.
8. Husted TL, Lentsch AB. The role of cytokines in pharmacological modulation of hepatic ischemia/reperfusion injury. Curr Pharm Des. 2006;12:2867-2873.
9. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5:975-979.
10. Zhai Y, Shen XD, Gao F, et al. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology. 2008;47:207-214.
11. Abu-Amara M, Yang SY, Tapuria N, et al. Liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transpl. 2010;16:1016-1032.
12. Ramana KV, Srivastava SK. Aldose reductase: a novel therapeutic target for inflammatory pathologies. Int J Biochem Cell Biol. 2010;42:17-20.
13. Srivastava SK, Yadav UC, Reddy AB, et al. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chem Biol Interact. 2011;191:330-338.
14. Yadav UC, Naura AS, Aguilera-Aguirre L, et al. Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice. J Immunol. 2009;183:4723-4732.
15. Ravindranath TM, Mong PY, Ananthakrishnan R, et al. Novel role for aldose reductase in mediating acute inflammatory responses in the lung. J Immunol. 2009;183:8128-8137.
16. Hwang YC, Kaneko M, Bakr S, et al. Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J. 2004;18:1192-1199.
17. Kaneko M, Bucciarelli L, Hwang YC, et al. Aldose reductase and AGERAGE pathways: key players in myocardial ischemic injury. Ann N Y Acad Sci. 2005;1043:702-709.
18. Cheng Q, Ng KT, Fan ST, et al. Distinct mechanism of small-for-size fatty liver graft injury-Wnt4 signaling activates hepatic stellate cells. Am J Transplant. 2010;10:1178-1188.
19. Ho HT, Chung SK, Law JW, et al. Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Mol Cell Biol. 2000;20:5840-5846.
20. Li CX, Shao Y, Ng KT, et al. FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells. PLoS One. 2012;7:e32380.
21. Man K, Shih KC, Ng KT, et al. Molecular signature linked to acute phase injury and tumor invasiveness in small-for-size liver grafts. Ann Surg. 2010;251:1154-1161.
22. Takahashi T, Hato F, Yamane T, et al. Activation of human neutrophil by cytokine-activated endothelial cells. Circ Res. 2001;88:422-429.
23. Qiu L, Lin J, Xu F, et al. Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-alpha and ameliorates hepatosteatosis in diabetic db/db mice. Exp Diabetes Res. 2012;2012:789730.
24. Thomas T, Rauscher F, Sanders R, et al. Effects of aldose reductase inhibitors on antioxidant defense in rat and rabbit liver. Toxicol Sci. 2000;53:145-149.
25. Twigg HL, III. Macrophages in innate and acquired immunity. Semin Respir Crit Care Med. 2004;25:21-31.
26. Palsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology. 2004;113:153-162.
27. Ulloa L, Tracey KJ. The "cytokine profile": a code for sepsis. Trends MolMed. 2005;11:56-63.
28. Kobayashi M, Tsuda Y, Yoshida T, et al. Bacterial sepsis and chemokines. Curr Drug Targets. 2006;7:119-134.
29. Ramana KV, Srivastava SK. Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages. Cytokine. 2006;36:115-122.
30. Chou RC, Kim ND, Sadik CD, et al. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity. 2010;33:266-278.
31. Fahmy RG, Waldman A, Zhang G, et al. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat Biotechnol. 2006;24:856-863.
32. Arndt PG, Young SK, Lieber JG, et al. Inhibition of c-Jun. N-terminal kinase limits lipopolysaccharide-induced pulmonary neutrophil influx. Am J Respir Crit Care Med. 2005;171:978-986.
33. Ramana KV, Bhatnagar A, Srivastava S, et al. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J Biol Chem. 2006;281:17652-17660.
34. Awasthi YC, Sharma R, Cheng JZ, et al. Role of 4-hydroxynonenal in stressmediated apoptosis signaling. Mol Aspects Med. 2003;24:219-230.
35. Ramana KV, Friedrich B, Bhatnagar A, et al. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J. 2003;17:315-317.
36. Ramana KV, Bhatnagar A, Srivastava SK. Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells. FASEB J. 2004;18:1209-1218.
37. Srivastava S, Chandra A, Bhatnagar A, et al. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem Biophys Res Commun. 1995;217:741-746.